Craneware plc Grant of Options & Long Term Incentive Plan Award (6721A)
28 March 2017 - 4:26AM
UK Regulatory
TIDMCRW
RNS Number : 6721A
Craneware plc
27 March 2017
Craneware plc
("Craneware" or the "Company")
Grant of Options
&
Long Term Incentive Plan Award
27 March 2017 - The Board of Craneware plc (AIM: CRW.L), the
market leader in Value Cycle solutions for the US healthcare
market, announces that on 24 March 2017, share options (the
"Options") to acquire ordinary shares of 1p each in the Company
("Shares") were granted to one of the Company's Directors as set
out below. The Options were granted pursuant to the terms of the
Craneware plc Schedule 4 Company Share Option Plan (2016) and the
Craneware plc Unapproved Share Option Plan (2016) (together, the
"Option Plans"), both of which were approved by shareholders at the
Company's AGM on 8 November 2016.
Director Aggregate no. Percentage of issued
of Shares over share capital
which Options
granted under
the Option Plans
--------------- ------------------ ---------------------
Craig Preston 8,586 0.03%
--------------- ------------------ ---------------------
The above Options have been granted at an exercise price of
1,237.50p per Share (being the closing market price on 23 March
2017). The Options will ordinarily become exercisable from the
third anniversary of grant, subject to (i) the satisfaction of
certain performance conditions based on the Company's total
shareholder return ("TSR") performance relative to the performance
achieved by a group of comparable companies in the same sector and
(ii) the Director's continued employment. These performance
conditions are measured in three tranches such that one third of
the Shares over which the Options subsist will vest based on
performance over the three years ending on 30 June 2017, one third
based on performance over the three years ending 30 June 2018 and
the final third based on performance over the three years to 30
June 2019 - an aggregate five year period. Any tranche (or part
thereof) that does not meet the performance criteria will lapse and
not be re-tested in later years.
The Company further announces that on 24 March 2017, under the
terms of the Craneware plc Long Term Incentive Plan (2016)
("LTIP"), which was also approved by shareholders at the Company's
AGM on 8 November 2016, a conditional award of Shares was granted
to a Director of the Company as follows:
Director No. of Shares Percentage of
over which a conditional issued share capital
share award was
granted
--------------- -------------------------- ----------------------
Craig Preston 8,586 0.03%
--------------- -------------------------- ----------------------
There was no consideration for the grant of the award and no
consideration will be payable by the award holder to receive the
Shares from this award, if and to the extent that it vests. The
award will ordinarily vest after three years subject to (i) the
satisfaction of TSR performance conditions that are substantively
the same as those described above in relation to the Options and
(ii) the Director's continued employment.
PDMR notification: Craig Preston
1. Details of the Restricted Person / person closely associated with him or her
a) Name Craig Preston
2. Reason for the notification
a) Position / status CFO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of
Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction Grant of options and Grant of
conditional share award
d) Price(s) and volume(s)
Volume(s) Price(s)
---------- ---------
8,586 nil
---------- ---------
8,586 nil
---------- ---------
e) Aggregated information:
i. Aggregated volume Aggregate volume 17,172
ii. Price Price(s) nil
f) Date of the transaction 2017-03-24
g) Place of the transaction London Stock Exchange, (XLON); AIM
For further information, please contact:
Craneware plc Peel Hunt Alma
+44 (0)131 +44 (0)20 7418 +44 (0)208 004
550 3100 8900 4218
Keith Neilson, Dan Webster Caroline Forde
CEO
Craig Preston, Adrian Trimmings Hilary Buchanan
CFO
George Sellar Robyn McConnachie
Josh Royston
About Craneware
Craneware enables healthcare providers to improve margins and
enhance patient outcomes so they can continue to provide quality
outcomes for all.
Craneware is the leader in automated value cycle solutions that
help US Healthcare provider organisations discover, convert and
optimise assets to achieve best clinical outcomes and financial
performance. Founded in 1999, Craneware is headquartered in
Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix
employing over 250 staff. Craneware's market-driven, SaaS solutions
normalise disparate data sets, bringing in up-to-date regulatory
and financial compliance data to deliver value at the points where
clinical and operational data transform into financial
transactions, creating actionable insights that enable informed
tactical and strategic decisions. To learn more, visit
craneware.com and thevaluecycle.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKODBOBKDBNB
(END) Dow Jones Newswires
March 27, 2017 13:26 ET (17:26 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2024 to May 2024
Craneware (LSE:CRW)
Historical Stock Chart
From May 2023 to May 2024